Geron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.

CEO

Harout Semerjian

CEOHarout Semerjian

Employees

229

Employees229

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1990

Founded1990

Employees

229

Employees229

GERN Key Statistics

Market cap

928.31M

Market cap928.31M

Price-Earnings ratio

-11.02

Price-Earnings ratio-11.02

Dividend yield

—

Dividend yield—

Average volume

9.94M

Average volume9.94M

High today

$1.49

High today$1.49

Low today

$1.40

Low today$1.40

Open price

$1.41

Open price$1.41

Volume

5.88M

Volume5.88M

52 Week high

$4.83

52 Week high$4.83

52 Week low

$1.09

52 Week low$1.09

GERN News

TipRanks 3d

Geron Corporation’s Phase 3 Study on Imetelstat: A Potential Game-Changer for Myelofibrosis Treatment

Geron Corporation ((GERN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!...

Analyst ratings

67%

of 9 ratings

Buy

66.7%

Hold

22.2%

Sell

11.1%

People also own

Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.